Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 10/22/21 EDT
326.01quote price arrow down-0.53 (-0.16%)
Volume
132,253
Close
326.54quote price arrow down-13.03 (-3.84%)
Volume
7,480,557
52 week range
65.49 - 497.49
Loading...
  • Open332.54
  • Day High335.75
  • Day Low317.18
  • Prev Close326.54
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low65.49
  • 52 Week Low Date10/28/20

Key Stats

  • Market Cap131.808B
  • Shares Out403.65M
  • 10 Day Average Volume9.92M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change212.57

KEY STATS

  • Open332.54
  • Day High335.75
  • Day Low317.18
  • Prev Close326.54
  • 52 Week High497.49
  • 52 Week High Date08/10/21
  • 52 Week Low65.49
  • 52 Week Low Date10/28/20
  • Market Cap131.808B
  • Shares Out403.65M
  • 10 Day Average Volume9.92M
  • Dividend-
  • Dividend Yield-
  • Beta1.52
  • YTD % Change212.57

RATIOS/PROFITABILITY

  • EPS (TTM)8.01
  • P/E (TTM)40.76
  • Fwd P/E (NTM)7.42
  • EBITDA (TTM)3.918B
  • ROE (TTM)72.43%
  • Revenue (TTM)7.02B
  • Gross Margin (TTM)84.20%
  • Net Margin (TTM)49.79%
  • Debt To Equity (MRQ)7.26%

EVENTS

  • Earnings Date11/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO6:5706:57
Google, AMD, Walmart & more stocks to watch: Pro Market Movers Oct. 22

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger RNA (mRNA). The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The Company develops technologies that enable the development of mRNA medicines for diverse applications. The Company...
Noubar Afeyan Ph.D.
Non-Executive Chairman
Stephane Bancel
Chief Executive Officer
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technology Officer
Lori Henderson J.D.
General Counsel
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
278.34-8.02-2.80%
ILMN
Illumina Inc
409.15-2.43-0.59%
REGN
Regeneron Pharmaceuticals Inc
572.36+2.99+0.53%
BIIB
Biogen Inc
264.80-5.41-2.00%
GRFS
Grifols SA
13.76-0.11-0.79%